Compass Capital Management, Inc Johnson & Johnson Transaction History

Compass Capital Management, Inc

$1.5 Billion
Q3 2024

A detailed history of Compass Capital Management, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Compass Capital Management, Inc holds 368,411 shares of JNJ stock, worth $57.7 Million. This represents 3.98% of its overall portfolio holdings.

Number of Shares

368,411

Previous 370,993 0.7%

Holding current value

$57.7 Million

Previous $54.2 Million 10.11%

% of portfolio

3.98%

Previous 3.66%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$145.48 - $167.38 $375,629 - $432,175	-2,582 Reduced 0.7%	368,411 $59.7 Million
Q2 2024 Jul 25, 2024	BUY	$144.38 - $157.78 $2.55 Million - $2.78 Million	17,648 Added 4.99%	370,993 $54.2 Million
Q1 2024 Apr 29, 2024	BUY	$155.22 - $162.74 $6.66 Million - $6.98 Million	42,888 Added 13.81%	353,345 $55.9 Million
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $1.68 Million - $1.83 Million	11,531 Added 3.86%	310,457 $48.7 Million
Q3 2023 Oct 27, 2023	SELL	$155.75 - $174.48 $1.64 Million - $1.84 Million	-10,520 Reduced 3.4%	298,926 $46.6 Million
Q2 2023 Jul 31, 2023	BUY	$154.35 - $166.11 $1.78 Million - $1.92 Million	11,556 Added 3.88%	309,446 $51.2 Million
Q1 2023 May 01, 2023	BUY	$151.05 - $180.26 $1.25 Million - $1.49 Million	8,244 Added 2.85%	297,890 $46.2 Million
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $1.77 Million - $1.99 Million	-11,045 Reduced 3.67%	289,646 $51.2 Million
Q3 2022 Oct 26, 2022	BUY	$161.33 - $179.52 $894,252 - $995,079	5,543 Added 1.88%	300,691 $49.1 Million
Q2 2022 Jul 27, 2022	SELL	$168.19 - $186.01 $4.79 Million - $5.29 Million	-28,459 Reduced 8.79%	295,148 $52.4 Million
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $705,936 - $801,689	4,464 Added 1.4%	323,607 $57.4 Million
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $2.24 Million - $2.49 Million	14,391 Added 4.72%	319,143 $54.6 Million
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $482,885 - $536,615	2,990 Added 0.99%	304,752 $49.2 Million
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $2.89 Million - $3.1 Million	18,145 Added 6.4%	301,762 $49.7 Million
Q1 2021 Apr 29, 2021	BUY	$153.07 - $170.48 $373,184 - $415,630	2,438 Added 0.87%	283,617 $46.6 Million
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $3.28 Million - $3.76 Million	23,913 Added 9.3%	281,179 $44.3 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $1.45 Million - $1.59 Million	10,326 Added 4.18%	257,266 $38.3 Million
Q2 2020 Aug 06, 2020	SELL	$128.81 - $155.51 $365,305 - $441,026	-2,836 Reduced 1.14%	246,940 $34.7 Million
Q1 2020 Apr 24, 2020	SELL	$111.14 - $153.99 $595,599 - $825,232	-5,359 Reduced 2.1%	249,776 $32.8 Million
Q4 2019 Jan 30, 2020	BUY	$127.5 - $146.44 $1.44 Million - $1.66 Million	11,311 Added 4.64%	255,135 $37.2 Million
Q3 2019 Oct 22, 2019	BUY	$126.95 - $142.14 $2.31 Million - $2.58 Million	18,166 Added 8.05%	243,824 $31.5 Million
Q2 2019 Jul 31, 2019	BUY	$131.15 - $144.24 $970,510 - $1.07 Million	7,400 Added 3.39%	225,658 $31.4 Million
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $675,996 - $751,650	5,377 Added 2.53%	218,258 $30.5 Million
Q4 2018 Jan 28, 2019	BUY	$122.84 - $147.84 $143,722 - $172,972	1,170 Added 0.55%	212,881 $27.5 Million
Q3 2018 Oct 31, 2018	BUY	$121.58 - $142.88 $199,999 - $235,037	1,645 Added 0.78%	211,711 $29.3 Million
Q2 2018 Jul 20, 2018	BUY	$119.4 - $131.76 $1.45 Million - $1.6 Million	12,119 Added 6.12%	210,066 $25.5 Million
Q1 2018 Apr 27, 2018	BUY	$125.1 - $148.14 $1.05 Million - $1.24 Million	8,357 Added 4.41%	197,947 $25.4 Million
Q4 2017 Jan 30, 2018	BUY	$131.22 - $143.62 $536,821 - $587,549	4,091 Added 2.21%	189,590 $26.5 Million
Q3 2017 Nov 01, 2017	BUY	$129.47 - $135.38 $24 Million - $25.1 Million	185,499	185,499 $24.1 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Compass Capital Management, Inc with notifications on news.

Account

Compass Capital Management, Inc Johnson & Johnson Transaction History